Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sclerosing peritonitis and propranolol

S Ahmad

    Chest
    |March 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    A man developed sclerosing peritonitis, a serious condition causing extensive adhesions and colonic hemorrhage, after taking propranolol for hypertension and angina. This case highlights a potential rare adverse effect of this common cardiovascular medication.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Induction of the angiogenic modulator fibroblast growth factor-binding protein by epidermal growth factor is mediated through both MEK/ERK and p38 signal transduction pathways.

    The Journal of biological chemistry·2001
    Same author

    Biliary atresia in an infant born to an HIV positive mother.

    Sexually transmitted infections·2001
    Same author

    Phylogenetic analysis of gram-positive bacteria based on grpE, encoded by the dnaK operon.

    International journal of systematic and evolutionary microbiology·2000
    Same author

    Low levels of ethanol stimulate and high levels decrease phosphorylation in microtubule-associated proteins in rat brain: an in vitro study.

    Alcohol and alcoholism (Oxford, Oxfordshire)·2000
    Same author

    Bioreactivity of glutathionyl hydroquinone with implications to benzene toxicity.

    Toxicology·2000
    Same author

    Two new diterpenoids from Salvia triloba.

    Fitoterapia·2000
    Same journal

    Wearable-derived activity and physiological changes following pleural intervention in malignant pleural effusion.

    Chest·2026
    Same journal

    The effect of a two-day stay at high altitude (2500 m) on right ventricular afterload and oxygen delivery in patients with pulmonary vascular disease A randomized controlled crossover trial.

    Chest·2026
    Same journal

    A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

    Chest·2026
    Same journal

    Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

    Chest·2026
    Same journal

    Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

    Chest·2026
    Same journal

    Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

    Chest·2026
    See all related articles

    Area of Science:

    • Gastroenterology
    • Cardiology
    • Pharmacology

    Background:

    • Propranolol is a beta-blocker commonly prescribed for hypertension and angina pectoris.
    • Sclerosing peritonitis is a rare condition characterized by inflammation and fibrosis of the peritoneum.

    Observation:

    • A 56-year-old male patient developed severe abdominal pain, weight loss, pleural effusion, and gastrointestinal hemorrhage.
    • The patient had been on propranolol (320 mg/day) for hypertension and angina since 1976.

    Findings:

    • Laparotomy revealed extensive peritoneal adhesions causing organ fixation.
    • Infectious and neoplastic causes were ruled out, suggesting a link to propranolol therapy.
    • This case presents sclerosing peritonitis with significant colonic involvement and hemorrhage potentially associated with propranolol.

    Related Experiment Videos

    Implications:

    • This case suggests a potential, albeit rare, association between long-term propranolol use and the development of sclerosing peritonitis.
    • Further investigation into the mechanisms underlying this adverse drug reaction is warranted.
    • Clinicians should be aware of this potential complication when managing patients on long-term propranolol therapy, especially those presenting with unexplained abdominal symptoms.